0 antall prosjekter

H20-HEALTH-Health, demographic change and wellbeing

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

Tildelt: kr 32,1 mill.

Prosjektperiode: 2020-2025

Sted: Oslo og 3 andre

H20-MSCA-Marie Sklodowska-Curie actions

Directing the immune response through designed nanomaterials

Directing the immune response through designed nanomaterials

Tildelt: kr 3,1 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Multiomics based analysis of brain-gut axis: A search for gastrointestinal disease phenotypes

An intimate yet less known relation between human brain and gut is rapidly emerging as several recent studies have identified various alterations within brain as a result of gastrointestinal disorders and reported comparable variations in gastrointestinal system due to altered brain outputs. Thes...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2020-2022

Sted: Vestland

H20-ERC-European Research Council

Outsourcing cancer immunity to healthy donors

Outsourcing cancer immunity to healthy donors

Tildelt: kr 19,7 mill.

Prosjektperiode: 2020-2025

Sted: Oslo

H20-SECURITY-Secure societies - Protecting freedom and security of Europe and its citizens

A SECURE HEALTHCARE ENVIRONMENT FOR INFORMATICS RESILIENCE

A SECURE HEALTHCARE ENVIRONMENT FOR INFORMATICS RESILIENCE

Tildelt: kr 5,7 mill.

Prosjektperiode: 2020-2023

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Tildelt: kr 8,6 mill.

Prosjektperiode: 2020-2025

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

The overall objective of this 5-year project is to build a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, based on existing initiatives, experience and expertise, allowing European expansion of DisCoVeRy (WP1) and the establishment of a COVID19 adaptive ...

Tildelt: kr 11,5 mill.

Prosjektperiode: 2020-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Tildelt: kr 0,63 mill.

Prosjektperiode: 2020-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

Tildelt: kr 8,3 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.

Breast Cancer (BC) is the first cause of cancer-related death in women worldwide. Breast cancer is classified into well-recognized molecular subtypes. Despite solid pre-clinical evidence, only some patients benefit from administering drug combinations, an indication that patient and tumor heterog...

Tildelt: kr 18,4 mill.

Prosjektperiode: 2020-2024

Sted: Trøndelag - Trööndelage og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

RELIABLE TECHNOLOGIES AND MODELS FOR VERIFIED WIRELESS BODY-CENTRIC TRANSMISSION AND LOCALIZATION

RELIABLE TECHNOLOGIES AND MODELS FOR VERIFIED WIRELESS BODY-CENTRIC TRANSMISSION AND LOCALIZATION

Tildelt: kr 0,59 mill.

Prosjektperiode: 2020-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Tildelt: kr 21,2 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms

Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms

Tildelt: kr 15,0 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer

Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer

Tildelt: kr 7,3 mill.

Prosjektperiode: 2019-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Tildelt: kr 2,3 mill.

Prosjektperiode: 2019-2025

Sted: Rogaland

H20-MSCA-Marie Sklodowska-Curie actions

CLoud ARtificial Intelligence For pathologY

CLoud ARtificial Intelligence For pathologY

Tildelt: kr 11,5 mill.

Prosjektperiode: 2019-2023

Sted: Rogaland og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Exploitation of the SECRETory pathway for cancer therapy to address European research

Exploitation of the SECRETory pathway for cancer therapy to address European research

Tildelt: kr 4,6 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-ERC-European Research Council

Brains and minds in transition: The dark side of neuroplasticity during sensitive life phases

The potential and boundaries of the human mind is determined by dynamic interactions between the environment and the individual genetic architecture. However, despite several breakthroughs, the genetic revolution has not provided a coherent account of the development of the mind and its disorders...

Tildelt: kr 13,9 mill.

Prosjektperiode: 2019-2024

Sted: Oslo

H20-ERC-European Research Council

How distress alters opioid drug effects and abuse liability

As the opioid epidemic escalates, we must ask: why are opioids so addictive? Non-human animal research links addiction with the powerful relief opioids can offer to animals in distress. In humans, epidemiological and clinical studies converge upon social stressors and a poor social support networ...

Tildelt: kr 14,4 mill.

Prosjektperiode: 2019-2024

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation

Glioblastoma is not only the most frequent but also the most malignant tumour originating in the Central Nervous System. Due to the extremely complex and heterogeneous molecular biology of this tumour “the same treatment for all” approach does not work well in this disease, and standard of care i...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2019-2021

Sted: Oslo

H20-EURATOM-EURATOM

Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs

Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs

Tildelt: kr 3,1 mill.

Prosjektperiode: 2019-2024

Sted: Oslo og 2 andre

H20-LEIT-LEIT-ICT-Information and Communication Technologies

5G HEalth AquacultuRe and Transport validation trials

Healthcare, transport and food verticals are hugely important in Europe, in terms of jobs, size (collectively surpassing €3Trillion) and export trade. Moreover, they are vital from a social perspective, for better patient outcomes, safer transportation and safer and more sustainable food producti...

Tildelt: kr 23,9 mill.

Prosjektperiode: 2019-2022

Sted: Oslo og 2 andre

H20-FET-Future and Emerging Technologies

Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

Deep lying tumours like aggressive brain cancer remain very difficult to treat and existing therapies offer only marginal increase in survival rates. In the case of photomedical therapies they are very effective, but mainly limited by their insufficient depth of light penetration into tissue. Cur...

Tildelt: kr 18,8 mill.

Prosjektperiode: 2019-2024

Sted: Akershus og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI). There is ample evidence from epidemiological studies as well as (pre)clinical research that Nic...

Tildelt: kr 0,30 mill.

Prosjektperiode: 2019-2022

Sted: Rogaland og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

LIFEBOTS Exchange - creating a new reality of care and welfare through the inclusion of social robots.

LIFEBOTS Exchange - creating a new reality of care and welfare through the inclusion of social robots.

Tildelt: kr 2,1 mill.

Prosjektperiode: 2019-2023

Sted: Trøndelag - Trööndelage og 2 andre

H20-INFRA-Research infrastructures

Providing an open collaborative space for digital biology in Europe

EOSC-Life brings together the 13 Biological and Medical ESFRI research infrastructures (BMS RIs) to create an open collaborative space for digital biology. It is our joint response to the challenge of analysing and reusing the prodigious amounts of data produced by life-science. Managing and i...

Tildelt: kr 2,2 mill.

Prosjektperiode: 2019-2023

Sted: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY

Background: Many cutting-edge therapies rely on manipulating the adaptive immune system, which has evolved a vast diversity (repertoire) of immune receptors to recognize and remove pathogens and cancer cells. The sequence-data sets characterizing this Adaptive Immune Receptor Repertoire (i.e., AI...

Tildelt: kr 3,5 mill.

Prosjektperiode: 2019-2022

Sted: Oslo

H20-ERC-European Research Council

Oral bacteria as determinants for respiratory health

The oral cavity is the gateway to the lower respiratory tract, and oral bacteria are likely to play a role in lung health. This may be the case for pathogens as well as commensal bacteria and the balance between species. The oral bacterial community of patients with periodontitis is dominated by ...

Tildelt: kr 14,4 mill.

Prosjektperiode: 2019-2023

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

European Joint Programme on Rare Diseases

As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profit from coordination on a European and international scale. RD research should be improved to overcome fragmentation, leading to efficacious use of data and r...

Tildelt: Skjult

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Living well, dying well. A research programme to support living until the end

Living well, dying well. A research programme to support living until the end

Tildelt: kr 3,3 mill.

Prosjektperiode: 2019-2022

Sted: Vestland